Remove 2004 Remove Ethics Remove Medical sales
article thumbnail

The Dark Side of KOL Relationship

Contrarian Sales Techniques

However, it was later discovered that the drug increased the risk of heart attacks and strokes, and it was eventually pulled from the market in 2004. It was revealed during the subsequent investigations that Merck had paid large sums of money to thought leaders in the medical community to promote Vioxx and downplay its risks.

Ethics 52